SpinChip Diagnostics ASA

Carnegie Investment Bank is proud to have acted as Joint Bookrunner in connection with SpinChip Diagnostics ASA’ NOK 145 million private placement.

The financing round was led by bioMérieux, a world leader in the field of in vitro diagnostics, with its NOK 115 million investment.

The proceeds from the financing round will be used to further advance SpinChip’s proprietary point-of care (POC) in vitro diagnostics platform, prepare for a CE mark in 2025, and for general corporate purposes.

Carnegie would like to congratulate SpinChip Diagnostics on the successfully completed private placement and are grateful for the vote of confidence.

Related articles

Navamedic ASA
Investment Banking

Navamedic ASA

Carnegie Investment Bank acted as Joint Bookrunner in connection with the NOK 95 million placing of...

Shearwater
Investment Banking

Shearwater

Carnegie Investment Bank is proud to have acted as Joint Lead Manager in connection with the...